Literature DB >> 7700637

Trichostatin A inhibits both ras-induced neurite outgrowth of PC12 cells and morphological transformation of NIH3T3 cells.

M Futamura1, Y Monden, T Okabe, J Fujita-Yoshigaki, S Yokoyama, S Nishimura.   

Abstract

During screening for inhibitors of ras-mediated differentiation of PC12 cells, trichostatin A (TSA) was isolated from the metabolites of Streptomyces as a potent inhibitor. TSA blocked both oncogenic ras- and NGF-induced neurite outgrowth from PC12 cells. However, addition of TSA 1 h after NGF-stimulation did not inhibit neuronal differentiation, suggesting that TSA affects an early step in the NGF-signaling pathway mediated by ras. Northern blotting analysis showed that TSA prolonged the maximum expression period of c=fos mRNA triggered by NGF and delayed its return to the basal level. TSA reduced c-jun mRNA induction by NGF but greatly enhanced c-myc mRNA induced by NGF. Yoshida et al. (J. Biol. Chem, 265, 17174-17179, 1990) showed that TSA inhibits histone deacetylation, which might influence the gene expression involved in cellular differentiation. In this study, we also found that TSA prevents histone deacetylation in PC12 cells as well as other cell lines, suggesting that inhibition of histone deacetylation by TSA might affect the expression of early-response genes. We also demonstrated that TSA induced reversion of oncogenic ras-transformed NIH3T3 cells to a normal morphology, suggesting that inhibitors of ras-mediated differentiation of PC12 cells may be effective as anticancer agents.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7700637

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  15 in total

Review 1.  Transcriptional transgene silencing and chromatin components.

Authors:  P Meyer
Journal:  Plant Mol Biol       Date:  2000-06       Impact factor: 4.076

2.  Identification of mouse histone deacetylase 1 as a growth factor-inducible gene.

Authors:  S Bartl; J Taplick; G Lagger; H Khier; K Kuchler; C Seiser
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

Review 3.  Rett syndrome and MeCP2: linking epigenetics and neuronal function.

Authors:  Mona D Shahbazian; Huda Y Zoghbi
Journal:  Am J Hum Genet       Date:  2002-11-19       Impact factor: 11.025

4.  Age-related macular degeneration (AMD) mitochondria modulate epigenetic mechanisms in retinal pigment epithelial cells.

Authors:  Sonali Nashine; Anthony B Nesburn; Baruch D Kuppermann; M Cristina Kenney
Journal:  Exp Eye Res       Date:  2019-06-19       Impact factor: 3.467

5.  Depudecin makes a debut.

Authors:  M L Privalsky
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

Review 6.  Prospects for the development of epigenetic drugs for CNS conditions.

Authors:  Moshe Szyf
Journal:  Nat Rev Drug Discov       Date:  2015-05-22       Impact factor: 84.694

7.  The expression of HDAC1 and HDAC2 during cerebellar cortical development.

Authors:  Ji Young Janice Yoo; Matt Larouche; Dan Goldowitz
Journal:  Cerebellum       Date:  2013-08       Impact factor: 3.847

Review 8.  Epigenetic interventions for epileptogenesis: A new frontier for curing epilepsy.

Authors:  Iyan Younus; Doodipala Samba Reddy
Journal:  Pharmacol Ther       Date:  2017-03-06       Impact factor: 12.310

9.  Net, a negative Ras-switchable TCF, contains a second inhibition domain, the CID, that mediates repression through interactions with CtBP and de-acetylation.

Authors:  P Criqui-Filipe; C Ducret; S M Maira; B Wasylyk
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

10.  Histone deacetylase 4 associates with extracellular signal-regulated kinases 1 and 2, and its cellular localization is regulated by oncogenic Ras.

Authors:  X Zhou; V M Richon; A H Wang; X J Yang; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.